Arena (AREN) had the highest return between October 3, 2016 and October 26, 2016 by a US stock, returning 330%.
| ASSET | DATE | % RETURN |
|---|---|---|
Arena (AREN) | 10/3/2016 - 10/26/2016 | 330% |
SurgePays (SURG) | 10/3/2016 - 10/26/2016 | 213.9% |
Intrusion (INTZ) | 10/3/2016 - 10/26/2016 | 212.3% |
Lexaria Bioscience (LEXX) | 10/3/2016 - 10/26/2016 | 129.03% |
CEA Industries (BNC) | 10/3/2016 - 10/26/2016 | 89.34% |
374Water Inc Common Stock (SCWO) | 10/3/2016 - 10/26/2016 | 87.5% |
Assembly Biosciences (ASMB) | 10/3/2016 - 10/26/2016 | 86.07% |
Zynex (ZYXI) | 10/3/2016 - 10/26/2016 | 82.37% |
Alpha Metallurgical Resources (AMR) | 10/3/2016 - 10/26/2016 | 69.05% |
Nutex Health (NUTX) | 10/3/2016 - 10/26/2016 | 63.17% |
Zivo Bioscience (ZIVO) | 10/3/2016 - 10/26/2016 | 60% |
AIxCrypto (AIXC) | 10/3/2016 - 10/26/2016 | 57.65% |
Aurora Cannabis (ACB) | 10/3/2016 - 10/26/2016 | 56.6% |
Anixa Biosciences (ANIX) | 10/3/2016 - 10/26/2016 | 55% |
Canopy Growth (CGC) | 10/3/2016 - 10/26/2016 | 51.16% |
InMed Pharmaceuticals (INM) | 10/3/2016 - 10/26/2016 | 49.8% |
OrganiGram (OGI) | 10/3/2016 - 10/26/2016 | 49.26% |
Aemetis (AMTX) | 10/3/2016 - 10/26/2016 | 48.67% |
Koss (KOSS) | 10/3/2016 - 10/26/2016 | 47.69% |
Sunshine Biopharma (SBFM) | 10/3/2016 - 10/26/2016 | 47.06% |
Skye Bioscience, Inc Common Stock (SKYE) | 10/3/2016 - 10/26/2016 | 43.48% |
Summit Therapeutics (SMMT) | 10/3/2016 - 10/26/2016 | 40.76% |
Avita Medical (RCEL) | 10/3/2016 - 10/26/2016 | 35.9% |
Quantum (QMCO) | 10/3/2016 - 10/26/2016 | 35.71% |
Madrigal Pharmaceuticals (MDGL) | 10/3/2016 - 10/26/2016 | 35% |
